
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bifidobacterium Lactis,Lactobacillus Gasseri,Lactobacillus Rhamnosus
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioma Probiotics Launches Women’s Gut Health Formula for Natural Weight Loss
Details : Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion naturally.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
August 05, 2025
Lead Product(s) : Bifidobacterium Lactis,Lactobacillus Gasseri,Lactobacillus Rhamnosus
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lysophosphatidylcholine-Rich Oil Extract
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : KGK Science
Deal Size : Inapplicable
Deal Type : Inapplicable
Lysoveta Trial to Assess Cognitive Function in Healthy Adult with Memory Complaints
Details : Lysophosphatidylcholine-Rich Oil Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 24, 2025
Lead Product(s) : Lysophosphatidylcholine-Rich Oil Extract
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : KGK Science
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Krill Oil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigation of Krill Oil in Women with Premenstrual Syndrome
Details : Krill Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Premenstrual Syndrome.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
September 05, 2024
Lead Product(s) : Krill Oil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Krill
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Glasgow
Deal Size : Inapplicable
Deal Type : Inapplicable
Investigating the Effects of Krill Oil and Krill Protein on Post-exercise Muscle Protein Metabolism
Details : Krill is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Hypertrophy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 17, 2023
Lead Product(s) : Krill
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Glasgow
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Omega-3 Fatty Acid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Uptake of an Omega-3 Oil in Healthy Adults
Details : Omega-3 Fatty Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 14, 2022
Lead Product(s) : Omega-3 Fatty Acid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BioTeSys GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Neurology
Study Phase : Preclinical
Recipient : Universite de Sherbrooke Department of Medicine
Deal Size : Undisclosed
Deal Type : Collaboration
Aker BioMarine Enters Into Research Collaboration for Alzheimer’s
Details : Université de Sherbrooke in Canada will test if LYSOVETA, Aker BioMarine’s new delivery platform based on LPC-bound EPA/DHA from krill, is more effective in increasing the concentration of DHA in the brain and improving cognition.
Product Name : Lysoveta
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 15, 2021
Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Recipient : Universite de Sherbrooke Department of Medicine
Deal Size : Undisclosed
Deal Type : Collaboration

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Superba Boost
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Atlantia Food Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Investigate the Effect of Superba Boost on the Skin.
Details : Superba Boost is a drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 10, 2019
Lead Product(s) : Superba Boost
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Atlantia Food Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : AKBM-3031
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : Ampel BioSolutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Omega-3 Replacement With Krill Oil in Disease Management of SLE
Details : AKBM-3031 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Lupus Erythematosus, Systemic.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 13, 2018
Lead Product(s) : AKBM-3031
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : Ampel BioSolutions
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Krill Oil
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
KOmparison Study KOmparison Study
Details : Krill Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 17, 2014
Lead Product(s) : Krill Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Krill Oil
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Investigate the Effects of Krill Oil on Fasting Serum Triglycerides
Details : Krill Oil is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 12, 2011
Lead Product(s) : Krill Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All